Correlation Between Mineralys Therapeutics, and IGM Biosciences
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and IGM Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and IGM Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and IGM Biosciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and IGM Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of IGM Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and IGM Biosciences.
Diversification Opportunities for Mineralys Therapeutics, and IGM Biosciences
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and IGM is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and IGM Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IGM Biosciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with IGM Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IGM Biosciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and IGM Biosciences go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and IGM Biosciences
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.28 times more return on investment than IGM Biosciences. However, Mineralys Therapeutics, Common is 3.63 times less risky than IGM Biosciences. It trades about -0.1 of its potential returns per unit of risk. IGM Biosciences is currently generating about -0.3 per unit of risk. If you would invest 1,120 in Mineralys Therapeutics, Common on November 9, 2024 and sell it today you would lose (115.00) from holding Mineralys Therapeutics, Common or give up 10.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. IGM Biosciences
Performance |
| Timeline |
| Mineralys Therapeutics, |
| IGM Biosciences |
Mineralys Therapeutics, and IGM Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and IGM Biosciences
The main advantage of trading using opposite Mineralys Therapeutics, and IGM Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, IGM Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IGM Biosciences will offset losses from the drop in IGM Biosciences' long position.| Mineralys Therapeutics, vs. Krystal Biotech | Mineralys Therapeutics, vs. Immunovant | Mineralys Therapeutics, vs. Foghorn Therapeutics | Mineralys Therapeutics, vs. Shattuck Labs |
| IGM Biosciences vs. Avidity Biosciences | IGM Biosciences vs. Cullinan Oncology LLC | IGM Biosciences vs. Mineralys Therapeutics, Common | IGM Biosciences vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |